U.S. federal trademark · Serial No. 97120355 · Reg. No. 7146620
Biological research and analysis; Industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, and pharmaceuticals for the treatment thereof; Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of pharmaceuticals and pharmaceutical therapies for the treatment of gastrointestinal (GI) diseases, inflammatory diseases, inflammatory bowel diseases (IBD), ulcerative colitis, ulcerative proctitis, Crohn's disease, immune checkpoint inhibitor-associated colitis (ICI-AC), exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, infectious diseases, and COVID-19 gastrointestinal infections; Research in the field of biopharmaceuticals; Scientific research and development
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.